Apogee Therapeutics, Inc. (APGE)
NASDAQ: APGE · Real-Time Price · USD
53.75
-0.22 (-0.41%)
Oct 14, 2025, 9:33 AM EDT - Market open
Apogee Therapeutics Market Cap
Apogee Therapeutics has a market cap or net worth of $3.52 billion as of October 14, 2025. Its market cap has increased by 7.65% in one year.
Market Cap
3.52B
Enterprise Value
2.93B
1-Year Change
7.65%
Ranking
Category
Stock Price
$53.75
Market Cap Chart
Since the IPO on July 14, 2023, Apogee Therapeutics's market cap has increased from $808.89M to $3.52B, an increase of 335.32%. That is a compound annual growth rate of 92.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 10, 2025 | 3.44B | 33.35% |
| Dec 31, 2024 | 2.58B | 92.13% |
| Dec 29, 2023 | 1.34B | 65.86% |
| Jul 14, 2023 | 808.89M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 748.25B |
| Johnson & Johnson | 459.32B |
| AbbVie | 407.19B |
| UnitedHealth Group | 321.06B |
| AstraZeneca | 264.75B |
| Novo Nordisk | 260.80B |
| Novartis AG | 253.85B |
| Abbott Laboratories | 230.73B |